These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 19781577

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein.
    Zhou Z, Khaliq M, Suk JE, Patkar C, Li L, Kuhn RJ, Post CB.
    ACS Chem Biol; 2008 Dec 19; 3(12):765-75. PubMed ID: 19053243
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Novel approaches to flavivirus drug discovery.
    Botting C, Kuhn RJ.
    Expert Opin Drug Discov; 2012 May 19; 7(5):417-28. PubMed ID: 22439769
    [Abstract] [Full Text] [Related]

  • 26. Development of novel antivirals against flaviviruses.
    Patkar CG, Kuhn RJ.
    Novartis Found Symp; 2006 May 19; 277():41-52; discussion 52-6, 71-3, 251-3. PubMed ID: 17319153
    [Abstract] [Full Text] [Related]

  • 27. De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus.
    Leal ES, Adler NS, Fernández GA, Gebhard LG, Battini L, Aucar MG, Videla M, Monge ME, Hernández de Los Ríos A, Acosta Dávila JA, Morell ML, Cordo SM, García CC, Gamarnik AV, Cavasotto CN, Bollini M.
    Eur J Med Chem; 2019 Nov 15; 182():111628. PubMed ID: 31472473
    [Abstract] [Full Text] [Related]

  • 28. The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell.
    Talarico LB, Pujol CA, Zibetti RG, Faría PC, Noseda MD, Duarte ME, Damonte EB.
    Antiviral Res; 2005 Jun 15; 66(2-3):103-10. PubMed ID: 15911027
    [Abstract] [Full Text] [Related]

  • 29. Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection.
    Alen MM, Kaptein SJ, De Burghgraeve T, Balzarini J, Neyts J, Schols D.
    Virology; 2009 Apr 25; 387(1):67-75. PubMed ID: 19264337
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. In vitro inhibition of dengue virus entry by p-sulfoxy-cinnamic acid and structurally related combinatorial chemistries.
    Rees CR, Costin JM, Fink RC, McMichael M, Fontaine KA, Isern S, Michael SF.
    Antiviral Res; 2008 Nov 25; 80(2):135-42. PubMed ID: 18606464
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
    Low JS, Wu KX, Chen KC, Ng MM, Chu JJ.
    Antivir Ther; 2011 Nov 25; 16(8):1203-18. PubMed ID: 22155902
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Dengue and other emerging flaviviruses.
    Solomon T, Mallewa M.
    J Infect; 2001 Feb 25; 42(2):104-15. PubMed ID: 11531316
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.